Novo Nordisk’s Wegovy Weight Loss Drug has experienced a meteoric increase in popularity.
Nurphoto | Pictures of getty
Novo Nordisk On Wednesday he said he would offer his weight loss drug for less than half of his usual price per month through a New online pharmacy to the consumer.
The cash payment The offer is available for millions of patients without insurance coverage for the box office injection. It aims to make Wegovy available to more people, while also ensuring that patients use brand medication instead of cheaper compounds that exploded in popularity during a scarcity again of Novo Nordisk’s drug.
The pharmacy, called Novocare, will allow patients pay $ 499 a month to the month for the weekly medicine. Wegovy’s list price before insurance and other sales is almost $ 1,350 per month.
The site can also send Wegovy recipes directly to patients’ houses through a specialized pharmacy partner. Novocare will also offer recharging reminders and access to live support for a company case manager, among other patient care services.
« Patients and prescribers have another option that provides convenient access to all Wegovy’s doses approved by the FDA at a reduced cost in our high quality pen, » said Dave Moore, executive vice president of American operations and global business development, in a statement.
Above all, the company said that in a « nearby future » it will extend the new savings offer for Wegovy to patients who pay cash who use traditional detail pharmacies, so that they can also pay a lower price.
Danish drug movement follows a similar strategy of its main rival Eli Lilly. The two companies are struggling to dominate the market from the so-called GLP-1s, which mimic some intestinal hormones to suppress the appetite and regulate blood sugar.
Eli Lilly in January 2024 launched His own online consumption pharmacy, Lillydirect, to help patients access their medication for weight loss.
The website allows eligible patients to get a recipe through a Telehealth provider and can provide home delivery. More recently Lillydirect also started offering Zepbound to Single dose roads they are half or even less than their monthly $ 1,000 list price.
In recent months, the food and drug administration has declared the United States scarcity of both Zepbound and Wegovy. This decision will prevent some pharmacies from creating non -approved versions of injections.
Novocare helps patients « avoiding the significant risks of the composite market, as is warned by respected organizations, experts from the medical community and the FDA, » Novo Nordisk said in a statement.
Leave a Reply